Ledger.Open graph →
SEC Form D · filed April 28, 2023

Allarity Therapeutics, Inc

Offering
—
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Douglas Frankiw · Vancouver, British Columbia, CanadaDirectorBrent Hunter · Vancouver, British Columbia, CanadaExecGeoffrey L. Butler · New York, NYDirectorAustin Willis · Coconut Creek, FLExecPatrick A. Rentz · Los Angeles, CAExec · DirectorGiovanni Y. Patuzzo · New York, NYExecRyan Black · FLORENCE, SCExecJoan G. Brown · Boston, MAExecJulian Fletcher · Grand Cayman, Cayman IslandsExecNicolin R. Decker · Broken Arrow, OKExec · DirectorGerald G. Mclaughlin · Boston, MADirectorMarie A. Foegh · Boston, MAExecJames G. Cullem · Boston, MAExec · DirectorThomas A. Jensen · Boston, MAExec · DirectorMichael Stocker · Vancouver, British Columbia, CanadaExec · DirectorSimon O. Trautmann · Doha, S3ExecDavid A. Roth · Boston, MADirectorSteen A. Knudsen · Boston, MAExecSachin S. Bavishi · SAN FRANCISCO, CADirectorNeil Branda · Vancouver, British Columbia, CanadaDirectorDirk Lange · Vancouver, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗